ICD-10-CM Billable Code

K71.50

Toxic liver disease with chronic active hepatitis without ascites

Clinical Classification Guidelines

Medical Intelligence & Overview

Toxic liver disease with chronic active hepatitis is a condition characterized by long-term inflammation of the liver caused by exposure to toxins or harmful substances. When this condition develops without the presence of ascites—the accumulation of fluid in the abdomen—it signifies a specific form of liver injury that can impair liver function over time. Recognizing the symptoms and understanding the causes of this disease are vital for timely management and treatment, although diagnosis and treatment should always be guided by healthcare professionals.

Causes & Symptoms

Clinical Causes: Chronic exposure to hepatotoxic substances such as alcohol, certain medications, or industrial chemicals Prolonged use of drugs known to cause liver toxicity, including some antibiotics and antifungal medications Ingestion of or contact with toxic plant or animal substances Repeated episodes of acute hepatitis leading to chronic inflammation Underlying metabolic or genetic conditions that predispose the liver to toxin accumulation

Key Symptoms: Fatigue and general weakness Persistent nausea or abdominal discomfort Loss of appetite and unexplained weight loss Jaundice, which appears as yellowing of the skin and eyes Dark urine and pale stool Swelling or tenderness in the upper right abdomen Elevated liver enzymes observed through blood tests

Diagnostic & Treatment

Diagnosis Path: Diagnosis of toxic liver disease with chronic active hepatitis involves a combination of medical history evaluation, physical examination, blood tests, and imaging studies. Key diagnostic steps include: - Blood tests to assess liver function, including ALT, AST, bilirubin, and alkaline phosphatase levels - Serological tests to rule out viral hepatitis - Liver biopsy to identify inflammation and exclude other liver conditions - Imaging techniques such as ultrasound to evaluate liver size, shape, and any structural abnormalities These steps help healthcare providers determine the extent of liver damage and the underlying cause, guiding effective management strategies.

Treatment Protocols: Treatment aims to halt or reverse liver damage, manage symptoms, and prevent disease progression. While specific treatment plans should be developed by healthcare providers, common approaches include: - Removing or reducing exposure to identified toxins or harmful substances - Discontinuing or adjusting medications that may contribute to liver toxicity - Supportive care with medications to manage symptoms and improve liver function - Nutritional counseling to promote liver health - Regular monitoring of liver function tests and clinical status - In severe cases, medical interventions such as corticosteroids or other immunosuppressive medications may be considered under specialist guidance Early diagnosis and intervention are essential for improving outcomes and preventing further liver deterioration.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is K71.50 a billable ICD-10 code?
Yes, K71.50 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report K71.50?
Clinical documentation must specify the nature of Toxic liver disease with chronic active hepatitis without ascites and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

disease hepatitis ascites chronic liver toxic active